About the Authors
- Adam Schayowitz
-
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
- Greg Bertenshaw
-
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
- Emiko Jeffries
-
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
- Timothy Schatz
-
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
- James Cotton
-
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
- Jessie Villanueva
-
Affiliation Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Meenhard Herlyn
-
Affiliation Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Clemens Krepler
-
Affiliation Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Adina Vultur
-
Affiliation Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Wei Xu
-
Affiliation Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
- Gordon H. Yu
-
Affiliation Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
- Lynn Schuchter
-
Affiliation Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
- Douglas P. Clark
-
* E-mail: dpclark@biomarkerstrategies.com
Affiliation BioMarker Strategies, Baltimore, Maryland, United States of America
Competing Interests
Authors DPC, AS, GB, EJ, TS, JC are paid employees of BioMarker Strategies, each with equity stake in the private commercial company. DPC is a co-founder and a member of the Board of Directors of BioMarker Strategies. BioMarker Strategies manufactures the SnapPath platform, a research use only instrument. The Company is currently engaged in the patent prosecution of three applications (U.S. Serial #: 13/089,219; 12/258,251; and 12/125,790). Authors LS and WX have received research support from BioMarker Strategies. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DPC AS GB LS GHY MH JV. Performed the experiments: EJ TS JC. Analyzed the data: DPC AS GB EJ TS JC JV AV CK MH WX GHY LS. Contributed reagents/materials/analysis tools: AS GB EJ TS JC JV AV CK MH WX GHY LS. Wrote the paper: DPC.